查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654274

医药快速微生物检测市场规模、份额、趋势分析报告：按产品、方法、应用、地区、细分市场预测，2025-2030 年

Pharmaceutical Rapid Microbiology Testing Market Size, Share & Trends Analysis Report By Product, By Technique, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

快速药物微生物检测市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球医药快速微生物检测市场预计到2030年将达到28亿美元，2025年至2030年期间的复合年增长率为17.53%。

这一市场的成长得益于生技药品和先进疗法需求的不断增长、监管压力的不断加大以及核酸检测等技术进步。

生产扩张还将包括对微生物污染高度敏感的生技药品、生物相似药、细胞疗法和疫苗。由于这些产品的复杂性和保质期短，快速的微生物检测至关重要。製药业正在经历快速成长，尤其是在印度、中国和巴西等新兴市场。这些地区对学名药、生物相似药、疫苗和生技药品生产设施的投资正在增加。一些生物製药製造商将其生产委託给 CMO，后者通常采用先进的快速微生物学检测技术来满足不同的客户需求和监管要求。例如，2024 年 1 月，Rapid Micro Biosystems, Inc. 宣布三星生物製剂公司 (Samsung Biologics) 采用其 Growth Direct 平台来增强其微生物品管流程。此次伙伴关係旨在提高效率、确保资料完整性并在三星製造框架内实现可扩展的品管业务。

此外，严格的法规遵循是製药业采用和发展快速微生物学检测的关键驱动因素。世界各地的监管机构都实施严格的微生物品管标准，以确保药品的安全性、有效性和品质。 FDA（美国）、EMA（欧洲）和WHO等机构要求严格遵守药典指南（USP、EP、JP等）进行无菌、微生物限量和微生物附着量测试。此外，PAT 等法律规范鼓励即时微生物监测，以确保製程控制和合规性。快速微生物检测方法非常适合整合到连续生产系统中。从而促进市场成长。

医药快速微生物检测市场报告重点

  • 按产品划分，试剂和套件部分在 2024 年占据最大的市场占有率。其中很大一部分是由于重复使用试剂和套件对生物製药进行快速微生物检测。
  • 根据方法论，基于成长的测试领域在 2024 年占据了市场主导地位。这些方法因其可靠性和被监管机构接受而被广泛使用。
  • 根据应用，无菌测试领域在 2024 年占据市场主导地位。快速微生物检测可确保注射剂和植入剂等无菌产品不含活微生物。
  • 2024年北美地区占38.16%的市场占有率。随着药物和疫苗开发时间表的加快，尤其是在 COVID-19 大流行期间，该地区对快速微生物学检测的需求不断增加，以快速满足监管要求和市场需求。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章。

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章 医药快速微生物检测市场：依产品分類的估计与趋势分析

  • 产品细分仪表板
  • 全球快速药物微生物检测市场产品趋势分析
  • 2018 年至 2030 年全球医药快速微生物检测市场规模及趋势分析（依产品划分）
  • 装置
  • 试剂和套件
  • 配件

第 5 章 医药快速微生物检测市场：依方法的估计与趋势分析

  • 方法论细分仪表板
  • 全球医药快速微生物检测市场方法变异分析
  • 2018 年至 2030 年全球医药快速微生物检测市场规模及趋势分析（依方法划分）
  • 基于成长的测试
  • 核酸检测
  • 基于细胞成分的测试
  • 基于可行性的检测
  • 其他的

第六章：快速药物微生物学检测市场：按应用分類的估计和趋势分析

  • 应用程式细分仪表板
  • 全球医药快速微生物检测市场应用变化分析
  • 2018 年至 2030 年全球医药快速微生物检测市场规模及趋势分析（依应用）
  • 原料检测
  • 微生物限量检测
  • 微生物附着量评估
  • 无菌测试
  • 其他的

第七章：快速药物微生物学检测市场：按地区分類的估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模、预测及趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与企业
  • 2024 年企业市场分析
  • 参与企业概况
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • BD
    • bioMerieux
    • Danaher
    • Sartorius AG
    • Abbott
    • QuidelOrtho Corporation
    • Charles River Laboratories
    • Rapid Micro Biosystems, Inc.
Product Code: GVR-4-68040-506-9

Pharmaceutical Rapid Microbiology Testing Market Growth & Trends:

The global pharmaceutical rapid microbiology testing market size is anticipated to reach USD 2.80 billion by 2030 and grow at a CAGR of 17.53% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market's growth is attributed to factors such as the increasing demand for biologics and advanced therapies, growing regulatory pressure, and technological advancements such as nucleic acid-based testing, and growing public concern about the safety of pharmaceuticals has pushed manufacturers to adopt advanced quality control measures, including rapid microbiology testing

Expanding manufacturing includes biologics, biosimilars, cell therapies, and vaccines, which are highly sensitive to microbial contamination. Due to their complexity and shorter shelf lives, rapid microbiology testing is critical for these products. The pharmaceutical industry is experiencing rapid growth, especially in emerging markets such as India, China, and Brazil. These regions are investing in manufacturing facilities for generics, biosimilars, vaccines, and biologics. Several biopharmaceutical manufacturers outsource production to CMOs, which often employ advanced rapid microbiology testing technologies to meet diverse client needs and regulatory requirements. For instance, in January 2024, Rapid Micro Biosystems, Inc. announced that Samsung Biologics had selected its Growth Direct platform to enhance microbial quality control processes. This partnership aims to improve efficiency, ensure robust data integrity, and allow for scalable quality control operations within Samsung's manufacturing framework.

Moreover, stringent regulatory compliance is a key driver of the adoption and growth of rapid microbiology testing in the pharmaceutical industry. Regulatory agencies worldwide impose rigorous microbial quality control standards to ensure the safety, efficacy, and quality of pharmaceutical products. Agencies such as the FDA (United States), EMA (Europe), and WHO require strict adherence to pharmacopeial guidelines (e.g., USP, EP, JP) for sterility, microbial limits, and bioburden testing. In addition, regulatory frameworks such as PAT encourage real-time microbial monitoring to ensure process control and compliance. Rapid microbiology methods integrate well with continuous manufacturing systems. Hence, driving the market growth.

Pharmaceutical Rapid Microbiology Testing Market Report Highlights:

  • Based on product, reagents and kits segment held the largest market share in 2024. The large share is due to the repetitive usage of reagents and kits for carrying out rapid microbiology tests for biopharmaceuticals.
  • Based on technology, the growth-based testing segment dominated the market in 2024. These methods are widely used due to their reliability and acceptance by regulatory agencies.
  • Based on application, the sterility testing segment dominated the market in 2024. Rapid microbiology testing ensures that sterile products, such as injectables and implantables, are free from viable microorganisms.
  • The North American region dominated the market share of 38.16% in 2024. Accelerated drug and vaccine development timelines, especially during the COVID-19 pandemic, have driven demand for rapid microbiology testing to meet regulatory requirements and market demands faster in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technique
    • 1.2.3. Application
  • 1.3. Information Analysis
  • 1.4. Market Formulation & Data Visualization
  • 1.5. Data Validation & Publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information Or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Rapid Microbiology Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technologies Advancements In Rapid Testing
      • 3.2.1.2. Increasing Focus On Quality Control And Rising Microbiology Testing Needs
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Expensive Equipment And Technology Hinder Market Adoption.
      • 3.2.2.2. Complex Regulations Slow Down The Approval And Implementation Process.
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Rapid Microbiology Testing Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Pharmaceutical Rapid Microbiology Testing Market Product Movement Analysis
  • 4.3. Global Pharmaceutical Rapid Microbiology Testing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Reagents & Kits
    • 4.5.1. Reagents & Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Accessories
    • 4.6.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Rapid Microbiology Testing Market: Technique Estimates & Trend Analysis

  • 5.1. Technique Segment Dashboard
  • 5.2. Global Pharmaceutical Rapid Microbiology Testing Market Technique Movement Analysis
  • 5.3. Global Pharmaceutical Rapid Microbiology Testing Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
  • 5.4. Growth-based Testing
    • 5.4.1. Growth-based Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Nucleic Acid-based Testing
    • 5.5.1. Nucleic Acid-based Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cellular Component-based Testing
    • 5.6.1. Cellular Component-based Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Viability-based Testing
    • 5.7.1. Viability-based Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Other Techniques
    • 5.8.1. Other Techniques Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Rapid Microbiology Testing Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Pharmaceutical Rapid Microbiology Testing Market Application Movement Analysis
  • 6.3. Global Pharmaceutical Rapid Microbiology Testing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Raw Material Testing
    • 6.4.1. Raw Material Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Microbial Limit Testing
    • 6.5.1. Microbial Limit Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Bioburden Assessment
    • 6.6.1. Bioburden Assessment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Sterility Testing
    • 6.7.1. Stability Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Other Applications
    • 6.8.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Rapid Microbiology Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. South Korea Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Pharmaceutical Rapid Microbiology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant's Overview
    • 8.3.1. Thermo Fisher Scientific Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Merck KGaA
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. BD
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. bioMerieux
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Danaher
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Sartorius AG
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Abbott
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. QuidelOrtho Corporation
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Charles River Laboratories
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Rapid Micro Biosystems, Inc.
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 5 Global pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global pharmaceutical rapid microbiology testing market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 10 North America pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 13 U.S. pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 16 Canada pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 19 Mexico pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 23 Europe pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 26 UK pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 29 Germany pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 France pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 31 France pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 32 France pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 35 Italy pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Spain pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 38 Spain pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 40 Denmark pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 41 Denmark pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Sweden pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 43 Sweden pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 44 Sweden pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 45 Norway pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 46 Norway pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 47 Norway pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 53 Japan pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 54 Japan pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 China pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 56 China pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 57 China pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 India pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 59 India pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 60 India pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 62 Australia pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 63 Australia pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 65 Thailand pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 66 Thailand pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 67 South Korea pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 68 South Korea pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 69 South Korea pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 72 Latin America pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 73 Latin America pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 75 Brazil pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 76 Brazil pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 78 Argentina pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 79 Argentina pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa pharmaceutical rapid microbiology testing market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 86 South Africa pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 92 UAE pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait pharmaceutical rapid microbiology testing market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait pharmaceutical rapid microbiology testing market, by technique, 2018 - 2030 (USD Million)
  • Table 95 Kuwait pharmaceutical rapid microbiology testing market, by application, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new services
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Pharmaceutical Rapid Microbiology Testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Pharmaceutical rapid microbiology testing market driver analysis
  • Fig. 12 Pharmaceutical rapid microbiology testing market restraint analysis
  • Fig. 13 Pharmaceutical rapid microbiology testing market: Porter's analysis
  • Fig. 14 Pharmaceutical rapid microbiology testing market: PESTEL analysis
  • Fig. 15 Pharmaceutical rapid microbiology testing market: Product outlook and key takeaways
  • Fig. 16 Pharmaceutical rapid microbiology testing market: Product market share analysis, 2024 - 2030
  • Fig. 17 Global pharmaceutical rapid microbiology testing market for instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global pharmaceutical rapid microbiology testing market for reagents & kits, 2018 - 2030 (USD Million)
  • Fig. 19 Global pharmaceutical rapid microbiology testing market for accessories, 2018 - 2030 (USD Million)
  • Fig. 20 Pharmaceutical rapid microbiology testing market: Technique outlook and key takeaways
  • Fig. 21 Pharmaceutical rapid microbiology testing market: Technique market share analysis, 2024 - 2030
  • Fig. 22 Global pharmaceutical rapid microbiology testing market for growth-based testing analysis, 2018 - 2030 (USD Million)
  • Fig. 23 Global pharmaceutical rapid microbiology testing market for nucleic acid-based testing, 2018 - 2030 (USD Million)
  • Fig. 24 Global pharmaceutical rapid microbiology testing market for cellular component-based testing, 2018 - 2030 (USD Million)
  • Fig. 25 Global pharmaceutical rapid microbiology testing market for viability-based testing, 2018 - 2030 (USD Million)
  • Fig. 26 Global pharmaceutical rapid microbiology testing market for other techniques, 2018 - 2030 (USD Million)
  • Fig. 27 Pharmaceutical rapid microbiology testing market: Application outlook and key takeaways
  • Fig. 28 Pharmaceutical rapid microbiology testing market: Application market share analysis, 2024 - 2030
  • Fig. 29 Global pharmaceutical rapid microbiology testing market for raw material testing, 2018 - 2030 (USD Million)
  • Fig. 30 Global pharmaceutical rapid microbiology testing market for microbial limit testing, 2018 - 2030 (USD Million)
  • Fig. 31 Global pharmaceutical rapid microbiology testing market for bioburden assessment, 2018 - 2030 (USD Million)
  • Fig. 32 Global pharmaceutical rapid microbiology testing market for sterility testing, 2018 - 2030 (USD Million)
  • Fig. 33 Global pharmaceutical rapid microbiology testing market for other applications, 2018 - 2030 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Canada pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Europe pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 UK pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Germany pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 France pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Italy pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Spain pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Norway pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Asia-Pacific pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Japan pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 China pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 India pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Australia pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 MEA pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 UAE pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait pharmaceutical rapid microbiology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Key company categorization
  • Fig. 64 Company market positioning
  • Fig. 65 Market participant categorization
  • Fig. 66 Strategy framework